Summary by Futu AI
The United States Securities and Exchange Commission (SEC) has declared the Form S-3 filing by 60 Degrees Pharmaceuticals, Inc. effective as of September 30, 2024, at 4:05 PM. This form is a registration statement that allows companies to issue various securities to the public. The effectiveness of this filing, under file number 333-282221, indicates that 60 Degrees Pharmaceuticals has met all the necessary regulatory requirements to proceed with the issuance of securities as detailed in their submission to the SEC.